These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 29783685

  • 1. Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria.
    Skočibušić M, Odžak R, Ramić A, Smolić T, Hrenar T, Primožič I.
    Molecules; 2018 May 18; 23(5):. PubMed ID: 29783685
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
    Odžak R, Skočibušić M, Maravić A.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7499-506. PubMed ID: 24126094
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
    Sader HS, Castanheira M, Jones RN, Flamm RK.
    Diagn Microbiol Infect Dis; 2017 Mar 01; 87(3):261-265. PubMed ID: 28069328
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS, Castanheira M, Flamm RK.
    Antimicrob Agents Chemother; 2017 Apr 01; 61(4):. PubMed ID: 28069649
    [Abstract] [Full Text] [Related]

  • 5. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I, Alonso N, Fernández-Martínez M, Zamorano L, Rivera A, Oliver A, Conejo MC, Martínez-Martínez L, Navarro F, Pascual A.
    Enferm Infecc Microbiol Clin; 2017 Oct 01; 35(8):499-504. PubMed ID: 27887765
    [Abstract] [Full Text] [Related]

  • 6. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA, Biedenbach DJ, Kazmierczak KM, Stone GG, Sahm DF.
    Antimicrob Agents Chemother; 2016 May 01; 60(5):2849-57. PubMed ID: 26926635
    [Abstract] [Full Text] [Related]

  • 7. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS, Lee WS, Bai KJ, Lam C, Hsu CW, Yu KW, Liao CH, Chang FY, Ko WC, Wu JJ, Chen YH, Chen YS, Liu JW, Lu MC, Liu CY, Chen RJ, Hsueh PR.
    J Microbiol Immunol Infect; 2015 Feb 01; 48(1):85-91. PubMed ID: 23973410
    [Abstract] [Full Text] [Related]

  • 8. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M, Ramakrishnan R, Ramesh S, Murugan N.
    Ophthalmic Res; 2012 Feb 01; 47(1):52-6. PubMed ID: 21720185
    [Abstract] [Full Text] [Related]

  • 9. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.
    Castanheira M, Mills JC, Costello SE, Jones RN, Sader HS.
    Antimicrob Agents Chemother; 2015 Feb 01; 59(6):3509-17. PubMed ID: 25845862
    [Abstract] [Full Text] [Related]

  • 10. New and Potent Quinuclidine-Based Antimicrobial Agents.
    Radman Kastelic A, Odžak R, Pezdirc I, Sović K, Hrenar T, Čipak Gašparović A, Skočibušić M, Primožič I.
    Molecules; 2019 Jul 23; 24(14):. PubMed ID: 31340589
    [Abstract] [Full Text] [Related]

  • 11. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J, Králiková K, Krcméry V, Schäfer V.
    J Chemother; 1999 Apr 23; 11(2):97-102. PubMed ID: 10326739
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
    Hackel M, Kazmierczak KM, Hoban DJ, Biedenbach DJ, Bouchillon SK, de Jonge BL, Stone GG.
    Antimicrob Agents Chemother; 2016 Aug 23; 60(8):4677-83. PubMed ID: 27216054
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility and beta-lactamase production of selected gram-negative bacilli from two Croatian hospitals: MYSTIC study results.
    Bedenic B, Goic-Barisic I, Budimir A, Tonkic M, Mihajkevic LJ, Novak A, Sviben M, Plecko V, Punda-Polic V, Kalenic S.
    J Chemother; 2010 Jun 23; 22(3):147-52. PubMed ID: 20566417
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 23; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 15. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia.
    Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN.
    Int J Antimicrob Agents; 2015 Jul 23; 46(1):53-9. PubMed ID: 25956844
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
    Sader HS, Castanheira M, Mendes RE, Flamm RK, Jones RN.
    Antimicrob Agents Chemother; 2017 Apr 23; 61(4):. PubMed ID: 28137811
    [Abstract] [Full Text] [Related]

  • 17. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S, Cascone C, Santagati M, Mezzatesta ML, Stefani S.
    Int J Antimicrob Agents; 2006 Nov 23; 28(5):396-401. PubMed ID: 17045463
    [Abstract] [Full Text] [Related]

  • 18. Beta-lactamase-producing Enterobacteriaceae in hospital effluents.
    Korzeniewska E, Harnisz M.
    J Environ Manage; 2013 Jul 15; 123():1-7. PubMed ID: 23563146
    [Abstract] [Full Text] [Related]

  • 19. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J, Dofferhoff AS, Mouton JW, Wagenvoort JH, van der Meer JW.
    Clin Microbiol Infect; 2008 Apr 15; 14(4):344-9. PubMed ID: 18261128
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A, Ishii Y, Aoki K, Testa R, Nichols WW, Tateda K.
    J Infect Chemother; 2015 Feb 15; 21(2):148-51. PubMed ID: 25444674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.